Tiny implant tested to fight weight and diabetes
NCT ID NCT05670379
Summary
This early-stage study tested a small, implanted device that slowly releases a drug called exenatide. It involved 24 overweight adults to see if the implant was safe and how the drug behaved in their bodies. The goal is to develop a long-term treatment option for managing weight and type 2 diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMax
Adelaide, Australia
Conditions
Explore the condition pages connected to this study.